Skip to main content

News

The safety and feasibility profile supports further investigation. CGT approaches like these offer a glimmer of hope for otherwise untreatable cancers, representing a long-sought potential for transformative, precision therapy in GBM.
A man with type 1 diabetes received CRISPR-edited donor insulin cells in his arm. They worked, made insulin, and survived without rejection—all without immune-suppressing drugs. It’s an early but groundbreaking step toward a real biological cure for type